메뉴 건너뛰기




Volumn 65, Issue 2, 2016, Pages 446-448

High mortality during direct acting antiviral therapy for hepatitis C patients with Child's C cirrhosis: Results of the Irish Early Access Programme

(22)  Gray, Emma a   O'Leary, Aisling b,c   Stewart, Stephen d   Bergin, Colm a,b   Cannon, Mary e   Courtney, Garry f   Crosbie, Orla g   De Gascun, Cillian F h   Fanning, Liam J i   Feeney, Eoin j   Houlihan, Diarmaid D j   Kelleher, Barry d   Lambert, Jack S d   Lee, John k   Mallon, Patrick d   McConkey, Sam e   McCormick, Aiden j   McKiernan, Susan b   McNally, Cora e   Murray, Frank e   more..


Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; BILIRUBIN; LEDIPASVIR PLUS SOFOSBUVIR; RIBAVIRIN; ANTIVIRUS AGENT;

EID: 84969964439     PISSN: 01688278     EISSN: 16000641     Source Type: Journal    
DOI: 10.1016/j.jhep.2016.03.022     Document Type: Letter
Times cited : (11)

References (2)
  • 1
    • 84962847001 scopus 로고    scopus 로고
    • Impact of direct acting antiviral therapy in patients with chronic hepatitis C and decompensated cirrhosis
    • [1] G.R. Foster, W.L. Irving, Cheung, M.C., Walker, A.J., Hudson, B.E., Verma, S., et al. Impact of direct acting antiviral therapy in patients with chronic hepatitis C and decompensated cirrhosis. J Hepatol 64 (2016), 1224–1231.
    • (2016) J Hepatol , vol.64 , pp. 1224-1231
    • Foster, G.R.1    Irving, W.L.2    Cheung, M.C.3    Walker, A.J.4    Hudson, B.E.5    Verma, S.6
  • 2
    • 84931560807 scopus 로고    scopus 로고
    • EASL recommendations on treatment of hepatitis C 2015
    • [2] EASL recommendations on treatment of hepatitis C 2015. J Hepatol 63 (2015), 199–236.
    • (2015) J Hepatol , vol.63 , pp. 199-236


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.